Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HALO | KRYS | KYMR | ||
| Company | Halozyme Therapeutic | Krystal Biotech Inc | Kymera Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 77.43 | 333.25 | 109.06 | ||
| High | 81.19 | 336.49 | 112.33 | ||
| Low | 76.82 | 326.08 | 107.40 | ||
| Latest | 80.84 | 327.50 | 110.38 | ||
| Change | +3.02 | -9.30 | +0.04 | ||
| % Change | +3.88% | -2.76% | +0.04% | ||
| Volume | 1,751,400 | 4,669,800 | 431,600 | ||
| 20-Day Average Volume | 1,824,670 | 601,695 | 1,067,015 | ||
| Previous Close | 77.82 | 336.80 | 110.34 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 77.69 | 358.84 | 113.71 | ||
| 20-Day Raw Stochastic | 86.95% | 4.35% | 21.48% | ||
| 20-Day Relative Strength | 63.06 | 45.90 | 56.75 | ||
| Weighted Alpha | +39.37 | +109.19 | +115.73 | ||
| Today's Opinion | 88% Buy | 56% Buy | 88% Buy | ||
| Previous Opinion | 88% Buy | 80% Buy | 88% Buy | ||
| Last Month's Opinion | 40% Buy | 100% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.26% since 07/16/26 | -4.18% since 07/16/26 | -3.17% since 07/16/26 | ||
| Low | 76.82 on 07/23/26 | 325.00 on 07/21/26 | 107.40 on 07/23/26 | ||
| High | 81.19 on 07/23/26 | 360.98 on 07/20/26 | 119.83 on 07/20/26 | ||
| 1-Month | |||||
| %Chg | +16.12% since 06/23/26 | -3.74% since 06/23/26 | +12.35% since 06/23/26 | ||
| Low | 69.72 on 06/24/26 | 325.00 on 07/21/26 | 97.86 on 06/24/26 | ||
| High | 82.26 on 07/07/26 | 382.54 on 06/30/26 | 130.05 on 06/25/26 | ||
| 3-Month | |||||
| %Chg | +21.40% since 04/23/26 | +22.18% since 04/23/26 | +26.63% since 04/23/26 | ||
| Low | 62.38 on 05/01/26 | 251.97 on 05/04/26 | 69.48 on 06/03/26 | ||
| High | 82.26 on 07/07/26 | 382.54 on 06/30/26 | 130.05 on 06/25/26 | ||
| 6-Month | |||||
| %Chg | +16.79% since 01/23/26 | +16.33% since 01/23/26 | +57.84% since 01/23/26 | ||
| Low | 61.33 on 03/27/26 | 242.00 on 03/31/26 | 68.29 on 01/26/26 | ||
| High | 82.26 on 07/07/26 | 382.54 on 06/30/26 | 130.05 on 06/25/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,230,463 | 9,928,860 | 9,076,348 | ||
| Shares Outstanding, K | 118,613 | 29,480 | 82,258 | ||
| Annual Sales | 1,396,610,000 | 389,130,000 | 39,210,000 | ||
| Annual Net Income | 316,890,000 | 204,830,000 | -311,350,000 | ||
| Last Quarter Sales | 376,710,000 | 116,360,000 | 34,370,000 | ||
| Last Quarter Net Income | 150,050,000 | 55,930,000 | -69,230,000 | ||
| 60-Month Beta | 0.84 | 0.50 | 1.95 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.60 on 05/11/26 | 1.83 on 05/04/26 | -0.71 on 04/30/26 | ||
| Earnings Date | 08/04/26 | 08/03/26 | 08/10/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 18.58 | 45.33 | 0.00 | ||